Get started
Author

Katharina Marth

Observed names: K Marth, K. Marth, Marth, K.
Institution: Klinik Hietzing
ORCID: 0000-0002-6012-5206
Observed ORCID: 0000-0002-6012-5206
OpenAlex ID: A5044428473
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
2014 · Margarete Focke-Tejkl, Milena Weber, et al. · Journal of Allergy and Clinical Immunology · 139
PDF
Heterogeneity of commercial timothy grass pollen extracts
2008 · M. Focke, K. Marth, et al. · Clinical & Experimental Allergy · 125
Allergen‐specific immunotherapy: from therapeutic vaccines to prophylactic approaches
2012 · R. Valenta, R. Campana, et al. · Journal of Internal Medicine · 113
PDF
Developments in allergen‐specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen‐specific immunoglobulin E and T cell reactivity
2010 · M. Focke, I. Swoboda, et al. · Clinical & Experimental Allergy · 113
PDF
CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells
2016 · Regina Selb, Julia Eckl-Dorna, et al. · Journal of Allergy and Clinical Immunology · 101
PDF
Mapping of Conformational IgE Epitopes with Peptide-Specific Monoclonal Antibodies Reveals Simultaneous Binding of Different IgE Antibodies to a Surface Patch on the Major Birch Pollen Allergen, Bet v 1
2011 · Anna Gieras, Petra Cejka, et al. · The Journal of Immunology · 88
PDF
Recombinant allergens: What does the future hold?
2011 · Rudolf Valenta, Katarzyna Niespodziana, et al. · Journal of Allergy and Clinical Immunology · 86
PDF
Molecular composition and biological activity of commercial birch pollen allergen extracts
2009 · M. Focke, K. Marth, et al. · European Journal of Clinical Investigation · 83
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
2014 · Katharina Marth, Margarete Focke-Tejkl, et al. · Current Treatment Options in Allergy · 79
PDF
A Nonallergenic Birch Pollen Allergy Vaccine Consisting of Hepatitis PreS–Fused Bet v 1 Peptides Focuses Blocking IgG toward IgE Epitopes and Shifts Immune Responses to a Tolerogenic and Th1 Phenotype
2013 · Katharina Marth, Isabella Breyer, et al. · The Journal of Immunology · 68
The majority of allergen‐specific IgE in the blood of allergic patients does not originate from blood‐derived B cells or plasma cells
2012 · J. Eckl‐Dorna, I. Pree, et al. · Clinical & Experimental Allergy · 59
Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen–allergic patients
2015 · Verena Niederberger, Katharina Marth, et al. · Journal of Allergy and Clinical Immunology · 47
Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults
2012 · Christian Lupinek, Katharina Marth, et al. · Journal of Allergy and Clinical Immunology · 43
PDF
Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy–treated mother
2009 · Sabine Flicker, Katharina Marth, et al. · Journal of Allergy and Clinical Immunology · 43
Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments
2015 · Raffaela Campana, Katharina Moritz, et al. · Journal of Allergy and Clinical Immunology · 40
Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction
2014 · M. Curin, M. Weber, et al. · Clinical & Experimental Allergy · 36
PDF
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
2018 · Raffaela Campana, Katharina Marth, et al. · Journal of Allergy and Clinical Immunology · 34
PDF
COVID-19 in a severe eosinophilic asthmatic receiving benralizumab – a case study
2020 · Andreas Renner, Katharina Marth, et al. · Journal of Asthma · 30
Tree Pollen Allergens
2014 · Katharina Marth, Tetiana Garmatiuk, et al. · CRC Press eBooks · 27
TRICOP – A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
2021 · Katharina Marth, Andreas Renner, et al. · Respiratory Medicine · 26
PDF
The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils
2012 · Katharina Blatt, Harald Herrmann, et al. · PLoS ONE · 26
PDF
Recombinant Allergens Promote Expression of Aminopeptidase-N (CD13) on Basophils in Allergic Patients
2008 · K. Sonneck, C. Baumgartner, et al. · International Journal of Immunopathology and Pharmacology · 25
Human monoclonal antibody–based quantification of group 2 grass pollen allergens
2004 · Katharina Marth, Margarete Focke, et al. · Journal of Allergy and Clinical Immunology · 22
PDF
Persistence of IgE-Associated Allergy and Allergen-Specific IgE despite CD4+ T Cell Loss in AIDS
2014 · Katharina Marth, Eva Wollmann, et al. · PLoS ONE · 21
PDF
Dupilumab rapidly improves asthma control in predominantly anti‐IL5/IL5R pretreated Austrian real‐life severe asthmatics
2021 · Andreas Renner, Katharina Marth, et al. · Immunity Inflammation and Disease · 20
PDF
Works count: 51
Citation count: 1,660
H-index: 22
I10-index: 33
Year
Topic
Type